These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30157197)

  • 1. Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti.
    McNairy ML; Jannat-Khah D; Pape JW; Marcelin A; Joseph P; Mathon JE; Koenig S; Wells M; Fitzgerald DW; Evans A
    PLoS One; 2018; 13(8):e0201945. PubMed ID: 30157197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after antiretroviral therapy during the expansion of HIV services in Haiti.
    McNairy ML; Joseph P; Unterbrink M; Galbaud S; Mathon JE; Rivera V; Jannat-Khah D; Reif L; Koenig SP; Domercant JW; Johnson W; Fitzgerald DW; Pape JW
    PLoS One; 2017; 12(4):e0175521. PubMed ID: 28437477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    Gupta-Wright A; Corbett EL; Wilson D; van Oosterhout JJ; Dheda K; Huerga H; Peter J; Bonnet M; Alufandika-Moyo M; Grint D; Lawn SD; Fielding K
    PLoS Med; 2019 Apr; 16(4):e1002776. PubMed ID: 30951533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.
    Koenig SP; Bernard D; Dévieux JG; Atwood S; McNairy ML; Severe P; Marcelin A; Julma P; Apollon A; Pape JW
    PLoS One; 2016; 11(2):e0146903. PubMed ID: 26901795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of mortality and loss to follow-up among adults enrolled in HIV care services in Rwanda.
    Mugisha V; Teasdale CA; Wang C; Lahuerta M; Nuwagaba-Biribonwoha H; Tayebwa E; Ingabire E; Ingabire P; Sahabo R; Twyman P; Abrams EJ;
    PLoS One; 2014; 9(1):e85774. PubMed ID: 24454931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
    Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
    BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort study.
    Smiley CL; Rebeiro PF; Cesar C; Belaunzaran-Zamudio PF; Crabtree-Ramirez B; Padgett D; Gotuzzo E; Cortes CP; Pape J; Veloso VG; McGowan CC; Castilho JL;
    Lancet HIV; 2021 May; 8(5):e266-e273. PubMed ID: 33891877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.
    Eduardo E; Lamb MR; Kandula S; Howard A; Mugisha V; Kimanga D; Kilama B; El-Sadr W; Elul B
    PLoS One; 2014; 9(7):e103864. PubMed ID: 25075743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of dropout from care among HIV-infected patients initiating antiretroviral therapy at a public sector HIV treatment clinic in sub-Saharan Africa.
    Asiimwe SB; Kanyesigye M; Bwana B; Okello S; Muyindike W
    BMC Infect Dis; 2016 Feb; 16():43. PubMed ID: 26832737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    Auld AF; Kerkhoff AD; Hanifa Y; Wood R; Charalambous S; Liu Y; Agizew T; Mathoma A; Boyd R; Date A; Shiraishi RW; Bicego G; Mathebula-Modongo U; Alexander H; Serumola C; Rankgoane-Pono G; Pono P; Finlay A; Shepherd JC; Ellerbrock TV; Grant AD; Fielding K
    PLoS Med; 2021 Sep; 18(9):e1003739. PubMed ID: 34491987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting.
    Nugent J; Edmonds A; Lusiama J; Thompson D; Behets F;
    Pediatr Infect Dis J; 2014 Nov; 33(11):1148-55. PubMed ID: 24945879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.
    Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE
    J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.
    Brinkhof MW; Dabis F; Myer L; Bangsberg DR; Boulle A; Nash D; Schechter M; Laurent C; Keiser O; May M; Sprinz E; Egger M; Anglaret X;
    Bull World Health Organ; 2008 Jul; 86(7):559-67. PubMed ID: 18670668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
    Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
    PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of mortality among HIV-infected people on antiretroviral treatment in East Africa: a sampling based approach in an observational, multisite, cohort study.
    Geng EH; Odeny TA; Lyamuya RE; Nakiwogga-Muwanga A; Diero L; Bwana M; Muyindike W; Braitstein P; Somi GR; Kambugu A; Bukusi EA; Wenger M; Wools-Kaloustian KK; Glidden DV; Yiannoutsos CT; Martin JN
    Lancet HIV; 2015 Mar; 2(3):e107-16. PubMed ID: 26424542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapy.
    Wang J; Yuan T; Ding H; Xu J; Keusters WR; Ling X; Fu L; Zhu Q; Li Q; Tang X; Cai W; Shang H; Li L; Zou H
    Lancet Reg Health West Pac; 2021 Nov; 16():100269. PubMed ID: 34590068
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients.
    Bisaso KR; Karungi SA; Kiragga A; Mukonzo JK; Castelnuovo B
    BMC Med Inform Decis Mak; 2018 Sep; 18(1):77. PubMed ID: 30180893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
    Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
    PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.